Background: The accelerated digital revolution in healthcare has greatly enhanced data management with electronic health records. Nonetheless, challenging issues of centralized control, privacy breaches, absence of patient ownership of their data, and inability to support decentralized scientific collaboration remain barriers to scalable healthcare research ecosystems. Recent developments in decentralized science (DeSci) create a paradigm shift, using blockchain, cryptographic primitives, and decentralized governance to facilitate transparent, trust-minimized, and collaborative biomedical research. This article provides a DeSci-friendly lightweight blockchain architecture that is used to support privacy-preserving and incentive-sensitive decentralized healthcare research infrastructure. Methods: The framework combines a permissioned blockchain with a lightweight hybrid consensus protocol, off-chain storage, and zero-knowledge proof-based authentication to permit secure and privacy-preserving access to data without revealing identity. Also, a tokenomics-based governance layer is proposed to support decentralized engagement, transparent policy implementation, and incentive-based research participation. The suggested system is tested in simulation with the following different network conditions and the key performance metrics such as latency, throughput, and computational cost. Results: Experiments prove that the suggested framework offers the following advantages:when compared to the current blockchain-based healthcare systems such as medical records, Fast Healthcare Interoperability Resources, and HealthChain. In addition, the framework goes past traditional data management by allowing a DeSci-oriented research life cycle, such as decentralized data contribution, validation, and provenance tracking. Conclusions: The proposed framework will help build scalable, secure, and patient-centered decentralized healthcare research ecosystems. Furthermore, the framework bridges the gap between blockchain-based healthcare systems and DeSci-driven research ecosystems.
The growth of artificial intelligence, distributed research networks, and data intensive clinical investigation is creating new opportunities for scientific collaboration while intensifying longstanding concerns involving privacy, transparency, provenance, and institutional trust. This discussion examines how decentralized infrastructure may support more accountable forms of open science, clinical research, and public-health reporting. The conversation considers the potential role of blockchain and related decentralized technologies in establishing verifiable data histories, strengthening research integrity, improving consent and access controls, and enabling multiple stakeholders to collaborate without relying entirely on a single centralized authority. It also explores the use of private artificial intelligence to derive value from sensitive health information while reducing unnecessary exposure of identifiable patient data. Particular attention is given to the distinction between making data widely available and creating systems through which data can be responsibly accessed, analyzed, validated, and governed. Decentralized research is presented not simply as a technical model, but as an institutional and governance challenge requiring clear accountability, interoperability, appropriate incentives, and meaningful protections for patients and research participants. The discussion concludes that decentralized infrastructure may offer a valuable foundation for trusted scientific collaboration, but its success will depend on implementation, governance, usability, and the ability to demonstrate measurable advantages over existing systems. The central challenge is therefore not whether decentralized technologies can be applied to health research, but whether they can be deployed in ways that strengthen evidence, protect individuals, and improve public confidence in the scientific process.
Blockchain promises records that can never be changed. In healthcare, this is often sold as a way to make data trustworthy. Here, the author argues that an unchangeable record solves only one part of the problem. It proves nobody altered the record after it was written. It does not prove the record was correct, identify who is responsible for it, or allow a patient to challenge a decision that turns out to be wrong. Using data-integrity rules already standard in regulated medicine, the author asserts that correcting mistakes and seeking a remedy are essential to the trust that blockchain in healthcare is meant to deliver.An unchangeable record proves only that data were not altered later, not that data were correct to begin with.Trustworthy medical systems must let errors be corrected while keeping a permanent, attributed trail of each correction.Europe’s right to erasure and the European Union Artificial Intelligence (EU AI) Act both assume records can change and decisions can be contested.A permanent record of a wrong decision that nobody can appeal protects the record, but it does not protect the patient.Regulated medicine solved this decades ago: append the correction, attribute it, timestamp it, and leave the original visible.
Background: The privacy and security of electronic health records (HER) in blockchain-based systems remains a major research problem because of high computational overhead and scalability restrictions. Privacy-preserving techniques such as encryption and zero-knowledge proofs strengthen blockchain’s transparency and immutability but often add significant latency and resource use. This study proposes a lightweight, simulation-based blockchain model balancing privacy protection and computational efficiency for healthcare data-sharing, incorporating hybrid encryption (AES with asymmetric-key exchange), zero-knowledge verification (zk-SNARK), and homomorphic aggregation to protect patient information while reducing processing cost. Methods: A five-stage simulation tested encryption/decryption latency, IPFS-based upload/download performance, proof generation/verification time, and scalability across key sizes, plus a sixth phase validating the framework on two real, publicly available, de-identified healthcare datasets—the Medical Information Mart for Intensive Care (MIMIC)-IV demo (100 real ICU patients) and the University of California “Diabetes 130-US Hospitals” dataset (101,766 real inpatient encounters). Every metric is reported as a mean with a 95% confidence interval from 15 to 20 repeated trials. Results: The AES-128 has the lowest overhead among tested key sizes (10% to 14% below AES-192/256), zk-SNARK verification averages 30.8 to 32.4 ms (n = 20 to 100 trials)—well within real-time requirements for on-chain access decisions—and proof generation and gas cost are statistically indistinguishable between a minimal baseline circuit and the consent-verification circuit, indicating negligible marginal overhead from the added consent logic. Computing cost scales linearly with data size: confirming lightweight scalability, withreal-data results closely tracking synthetic-data results, witha narrowly scoped comparison showing error correction code memory (ECC (memory (secp256r1) key exchange is 93.5% faster than RSA-3072 key wrapping. Conclusions: This work demonstrates that efficient cryptographic integration and optimization through simulation can produce a privacy-preserving blockchain for healthcare that streamlines EHR handling securely and at scale.
This ConV2X Decentralized Health 2026 executive roundtable explores how technology convergence impacts precision health outcomes. The dialogue focuses on the main technologies supporting precision health, the latest scientific developments, technology advancements, opportunities, and risks. It is moderated by BHTY journal editor Prof. Dr. Vasiliu-Feltes. Participants emphasize the latest scientific developments, opportunities, and risks associated with precision health, enabled by converging advanced technologies.
Objective: The authors evaluated how quantum computing threatens the cryptographic primitives used in Bitcoin and other blockchain systems. These findings were translated into a standards-aligned post-quantum migration profile for healthcare ledgers, including consent, identity, provenance, audit, and encrypted off-chain data exchange. Methodology: Narrative analysis, theoretical security analysis, and healthcare-oriented deployment mapping of classical public-key and hash primitives used in blockchain protocols were paired with an implementation-oriented migration profile based on finalized National Institute of Standards and Technology (NIST) post-quantum standards. We summarize the mathematical assumptions underlying RSA, Elliptic Curve Cryptography/Elliptic Curve Digital Signature Algorithm (ECC/ECDSA), and Secure Hash Algorithm (SHA-2/SHA-3-family) hash functions; analyze their susceptibility to Shor’s and Grover’s quantum algorithms; compare Federal Information Processing Standards (FIPS) 203 Module-Lattice-Based Key-Encapsulation Mechanism Standard (ML-KEM), FIPS 204 Module-Lattice-Based Digital Signature Standard (ML-DSA), and FIPS 205 Stateless Hash-Based Digital Signature Standard (SLH-DSA); and map their distinct roles to healthcare-ledger authorization, auditability, identity, and encrypted off-chain exchange. The term Advanced Hybrid Module-LWE & Code-Based (AHMC) is used only as shorthand for a standards-aligned hybrid post-quantum cryptography (PQC) migration profile and does not denote a proprietary product, a novel algorithm, or a new cryptographic primitive. Proposed adoption of hybrid, quantum-resistant cryptographic primitives for cryptocurrency wallets, transaction signatures, and ledger security during an interim migration period (hybrid classical + PQC, followed by PQC-only). Qualitative and implementation-oriented assessment of (1) break feasibility of RSA/ECC under Shor’s algorithm, (2) effective security reduction for hash functions under Grover’s algorithm, (3) security assumptions and composition requirements of a standards-aligned hybrid migration profile, (4) transaction-size and verification-cost impact, and (5) healthcare-specific implications for long-retention consent, identity, provenance, and audit records. Results: Shor’s algorithm reduces integer factorization and discrete logarithms to polynomial time, directly compromising Rivest–Shamir–Adleman (RSA) and ECC/ECDSA once fault-tolerant, large-scale quantum computers exist. Grover’s algorithm yields a quadratic speedup for brute-force search, effectively halving the security margin of symmetric keys and hash functions at fixed output sizes. The AHMC-L1/L3/L5 profiles use ML-KEM-512/768/1024 for key establishment and ML-DSA-44/65/87 for transaction authentication, with SLH-DSA as a hash-based fallback. During a hybrid ECDSA+PQC migration, verification requires one classical and one PQC verification per authorization; transaction-size overhead is dominated by PQC signatures, approximately 2.4 KB for ML-DSA-44, 3.3 KB for ML-DSA-65, and 4.6 KB for ML-DSA-87 before script and encoding overhead. For healthcare ledgers, these findings support selective use of post-quantum signatures for:Deployment suitability remains contingent on workflow-specific latency, storage, availability, key lifecycle, and side-channel testing. Conclusions: Quantum risk to blockchain signatures has direct implications for healthcare systems that depend on long-lived consent, identity, provenance, and audit records. A staged, standards-aligned migration profile can preserve authorization and ledger verifiability while keeping protected health information off-chain. The AHMC label refers only to this migration profile, not to a new cryptographic primitive; healthcare adoption requires open implementations, empirical benchmarking, crypto-agile key governance, and side-channel-resistant engineering.
Disease surveillance systems face delays in data collection, validation, and reporting at various levels, which undermines early detection and rapid response. Blockchain technology, as a transparent and immutable architecture, can accelerate the flow of epidemiological data and increase trust among actors, but the transition from idea to practical tool requires an analysis of requirements and limitations. This article examines the key challenges of applying blockchain in disease surveillance in two axes: first, governance challenges, data sovereignty, and the inherent conflict of decentralized architecture with epidemiological requirements and privacy laws; second, technical, infrastructural, and operational challenges such as digital identity, interoperability, communication limitations, economic model, and security vulnerabilities. Therefore, the conclusion shows that blockchain can only contribute to transparency and traceability in the form of permissioned/consortium networks with verified identity, and its true effectiveness depends on feasibility studies, piloting, and intelligent combination with data exchange standards and international cooperation. Blockchain can potentially improve transparency, traceability, and trust in surveillance systems.Real effectiveness requires feasibility studies, pilots, and detailed evaluations.The future of patient care lies in a combination of digital technologies, data exchange standards, and international collaboration.
The Coalition for Decentralized Healthcare and Life Sciences (CDHLS) brought together three pioneers at the intersection of medicine and decentralized technology for a candid conversation about what safe AI means for healthcare and how to make it so – including best practices. Themes addressed include: What is Safe AI? Data Sovereignty in Healthcare: who owns the AI model and its memory? Where does decentralization fit? How will it help reduce AI risk? What is next? This conversation is the second in a new podcast series launched in 2026 that dives into the decentralized science revolution. If you missed “What is DeSci,” click here to get up to speed. The series explores: Case studies of successful DeSci projects Interviews with researchers and policy makers Delve into tokenomics, DAOs, and data sovereignty The intersection of AI, biotech, and decentralized systems For CDHLS details visit https://blockchainhealthcaretoday.com/index.php/journal/CDHLS
Background: The secondary use of patient health data is critical for advancing clinical research, public health, and digital health innovation. However, traditional consent mechanisms are often static, complex, and insufficiently transparent, limiting patient control and trust. In response to regulatory requirements introduced by the General Data Protection Regulation (GDPR) and the European Health Data Space (EHDS), this article paper aims to design a secure, transparent, and revocable blockchain-based architecture for managing patient consent for the secondary use of health data, aligned with European legal frameworks and interoperability standards. Methods: A multilayered consent management architecture was designed by integrating blockchain smart contracts, decentralized identifiers, verifiable credentials, and Health Level Seven—Fast Healthcare Interoperability Resources. The system incorporates a patient-controlled digital wallet, off-chain health data storage, and on-chain enforcement of consent policies through smart contracts. Regulatory and technical requirements were systematically derived from GDPR and European Health EHDS provisions. The study follows a design science research methodology and includes threat modeling and a theoretical performance and scalability analysis. The design is guided by four core objectives: dynamic consent management, auditable governance, interoperability with healthcare standards, and compliance-by-design with European regulatory frameworks. Results: The proposed architecture enables secure creation, delegation, and revocation of patient consent through immutable blockchain-based logging and Fast Healthcare Interoperability Resources-compliant data exchange. Consent records are tamper-evident, while sensitive health data remain off-chain, ensuring data minimization and privacy protection. Consent attributes such as purpose limitation, duration, and data scope are explicitly modeled to comply with GDPR and EHDS requirements. Theoretical evaluation indicates that the architecture can scale to large healthcare data ecosystems when deployed on Ethereum-compatible blockchains combined with external storage solutions. Conclusions: This study presents a modular, standards-based consent management framework that enhances patient autonomy, supports regulatory compliance, and strengthens governance for the secondary use of health data. By combining blockchain, digital identity, and healthcare interoperability standards, the architecture addresses key legal and technical challenges of dynamic consent. Future work will focus on developing a user-centered prototype and conducting empirical validation in real-world secondary-use health data ecosystems.
Animal welfare issues occasionally make headlines and are a subject for continuous improvement. Inadequate living conditions and a lack of healthcare have led to constant violations of the Animal Welfare Acts in zoos. This can be improved by using a system to accurately manage crucial animal health data and make it accessible and shared between facilities. The aim of this article is to design a Hyperledger Fabric-based system, named the “Zoo Trust Database,” to enable seamless sharing of zoo animal data between zoos and conservation facilities. The system ensures that accurate healthcare data and medical histories of animals are securely recorded and accessible to authorized network peers at all times. The system will provide information to the regulatory authorities limiting the instances of violations in healthcare management of animals. This system has the potential to help facilities make better-informed treatment decisions while improving animal welfare.
Objective: This article introduces the ZK-PRET Business Process Prover framework that integrates Object Management Group (OMG) business process standards with zero-knowledge cryptographic verification to enable privacy-preserving healthcare process compliance across distributed systems. Methods: We developed a multilayer architecture combining formal business process modeling, zero-knowledge proof generation, and regulatory compliance verification. The framework extends established OMG standards with cryptographic verification capabilities to achieve verifiable compliance, privacy preservation, and regulatory accountability. Implementation testing were conducted in synthetic data environments designed to represent real-world healthcare scenarios.1 These environments enable comprehensive modeling and testing of multi-entity process orchestration patterns while maintaining privacy protections essential for healthcare research and development. All scenarios, clinical examples, and process expressions presented in this article utilize synthetic data to ensure no real patient data, clinical records, or identifiable health information were used. Results: The ZK-PRET Business Process Prover framework demonstrates practical applicability across many healthcare domains, including treatment planning, telemedicine coordination, healthcare administration, consumer health services, multientity clinical trials, and supply chain management. Implementation results demonstrate cryptographic verification capabilities that enable mathematical prevention of regulatory violations rather than post hoc detection. The results demonstrate configurable privacy preservation through zero-knowledge verification and consistent proof sizes suitable for modeling complex orchestrations, while leveraging already widely used Web 2 process models suitable for multiple runtime deployment topologies. Conclusions: Zero-knowledge healthcare process verification represents a foundational technology for regulatory compliance in distributed healthcare systems. While agentic AI systems present important opportunities for automation, the underlying requirement for verifiable process compliance through cryptographic means brings broader challenges. ZK-PRET Business Process Prover addresses these challenges in healthcare transformative flows, enabling safer deployment of autonomous systems while maintaining regulatory standards.
The Internet of Medical Things is revolutionizing the concept of patient care. It is empowering the implementation of remote patient care protocols through the use of body sensors to monitor vital signs. However, it produces vast amounts of information, which raises security and privacy concerns. High-dimensional medical data are essential for diagnosis and treatment, but they are not currently connected to blockchain-based electronic health record systems. To overcome these limitations, the authors present a Hyperledger Fabric-based secure remote patient monitoring model for storing and retrieving medical imaging. The system records patient vital signs using sensors and stores medical images off-chain in the InterPlanetary File System. This model uses two organizations and a single channel, with Raft consensus, to ensure data consistency and high performance. Additionally, this study evaluates the performance of the proposed system in terms of throughput and latency. A test was conducted at 1,200 transactions with varying transfer rates. The results reveal that the throughput was near the send rate, up to 90 TPS. At a send rate of 150 TPS, the system reaches its peak throughput of 117.04 TPS. Moreover, no transactions were lost, which means that the system was able to make all its transactions, representing system reliability. The latency was noted to be 0.21 to 2.24 s, whereas the read operation was always characterized by the same latency of 0.01 s.
Objectives: The authors explore how large pharmaceutical corporations may integrate emerging decentralized technologies—such as blockchain and decentralized autonomous organizations (DAOs)—within their merger, acquisition and partnership frameworks, and how these strategies intersect with broader innovation and external sourcing models. In this context, blockchain is considered primarily as an enabling infrastructure for decentralized governance and programmable coordination—supporting mechanisms such as tokenized incentives, auditable decision trails, and new forms of intellectual property (IP) and collaboration structures. Methods: This study employed a qualitative case study methodology, combining document analysis and semi-structured interviews with internal stakeholders from a leading large-cap pharmaceutical company (herein after “Company”). Participants included executives and professionals from corporate development, scientific research, external innovation, and digital strategy units.The analysis examined how a large-cap “Company” approaches mergers, acquisitions, and partnerships, and how emerging technologies may influence these frameworks. The study focused on strategy alignment, organisational attitudes towards decentralisation, integration constraints, and perceptions of innovation value along the external sourcing continuum. Results: Acquisition and innovation strategy by the “Company” is driven by long-term alignment between external opportunities and internal priorities. Over time, the “Company” increasingly turned to external sources of innovation, leveraging technologies to improve innovation scouting, target identification, and operational forecasting. While decentralisation technologies such as DAOs are viewed as promising for early-stage innovation and collaboration, their integration is hindered by legal ambiguity, internal governance rigidity, and unfamiliarity with token-based economics. The “Company” views mergers and acquisitions (M&As) and licensing as critical to sustaining its pipeline, and sees potential for emerging technologies to accelerate preclinical decision-making and improve visibility into academic and biotech ecosystems. Conclusions: This study contributes insights into how large-cap pharmaceutical firms might adapt their innovation models in response to technological change and external pressures. While established mechanisms such as M&A and partnerships remain dominant, digital and decentralized technologies offer complementary tools for scouting, collaboration, and portfolio expansion.
I recently came across a LinkedIn post from Matt Hodgkinson, DOAJ’s Head of Editorial, about Fengkai Group, a Hong Kong based communications company. Apparently, they are offering paid positions as guest editors for special issues in journals indexed in SCI and Ei Compendex. If you’re familiar with publication ethics, DOAJ, or the Committee on Publication Ethics (COPE), this raises an immediate concern.
This systematic review examines how blockchain is applied in clinical data management (CDM) and what prevents its adoption in healthcare. A structured search in Scopus and Web of Science retrieved 554 records; after applying inclusion/exclusion criteria and quality assessment, 32 studies published between 2018 and 2024 were included. The analysis was guided by five research questions: (1) how blockchain supports clinical data workflows; (2) its role in data security and privacy; (3) key technical challenges and commonly used technologies; (4) integration with other healthcare technologies, and (5) how does blockchain technology integrate with and enhance other emerging healthcare technologies? Findings show that blockchain can support consent management, secure data sharing, traceability, and tamper-resistant audit trails using smart contracts and decentralized access control. It is also positioned as a trust layer for electronic health records, the Internet of Medical Things, artificial intelligence, and telemedicine by ensuring integrity and controlled access to sensitive clinical data. However, several barriers limit real-world deployment. Reported challenges include limited scalability and throughput, difficulty integrating with legacy electronic health record systems, heterogeneous regulatory requirements, and the complexity of encoding privacy, consent, and compliance into smart contracts. Ethereum and Hyperledger Fabric are the most frequently implemented platforms, often combined with off-chain storage and interoperability standards such as Fast Healthcare Interoperability Resources (FHIR)/Substitutable Medical Applications and Reusable Technologies on FHIR. Overall, blockchain shows strong potential to improve security, transparency, and cross-institution exchange in CDM, but its viability depends on addressing scalability, interoperability, and governance constraints. However, the evidence base remains heterogeneous, and only a minority of studies report quantitative benchmarks or real-world deployments, which limits cross-study comparability and generalizability.
The “BlockCare” addresses the growing challenge of managing and accessing personal health records scattered across various healthcare providers. Patients often struggle with fragmented and inaccessible health information, leading to delays and potential errors in their care.1,2 We have expanded the system’s technical architecture to ensure interoperability and compliance with global healthcare regulations. BlockCare offers a secure, centralized platform where users can store, manage, and easily access their complete health data, including medical history, lab results, and treatment records.3,4 Detailed security mechanisms such as cryptographic hashing, multi-signature authentication, and a decentralized access control model have been incorporated.5 Utilizing advanced encryption and robust authentication methods, the app ensures the highest level of data privacy and security.6,7 It integrates seamlessly with different healthcare systems, providing real-time updates and allowing users to share their information effortlessly with healthcare professionals.8 The intuitive interface simplifies the process of retrieving and managing health records, empowering patients to make informed decisions about their care and improving overall care coordination.9,10 The manuscript now discusses compliance with Health Insurance Portability and Accountability and General Data Protection Regulation, ensuring legal and ethical handling of sensitive health data.11 Countries like Greece, where comprehensive regulatory frameworks for electronic health record (her) adoption are still emerging, could greatly benefit from decentralized health record solutions like BlockCare.
Metaverse is heralded by some as the next iteration of the internet. It offers three-dimensional, immersive virtual spaces, where users, represented as avatars, can synchronously work, play, interact, and transact. Initially developed within the realm of massive multiplayer online role-playing games, the metaverse now extends into sectors such as music, entertainment, retail, real estate, and, more recently, healthcare. Users engage in the metaverse using augmented reality or virtual reality (AR/VR) headsets that interoperate with other sensory devices to integrate biofeedback and multimodal data streams.1 In this article, the authors offer a conceptual synthesis and anticipatory policy analysis grounded in a narrative review of current trends reported in public-facing news reports as well as interdisciplinary sources from bioethics, law, digital-health policy, and science-and-technology studies. There are seven key ethical, legal, and social issue areas for consideration in the delivery of metaverse-enabled healthcare. We additionally issue a call to action to explore the metaverse through a bioethics lens. The authors begin by providing a primer on the metaverse, including the various forces shaping its development. Next, the authors describe what distinguishes the metaverse from other digital-health technologies and illustrate emerging use cases for the metaverse. We then outline what we consider the most pressing ethical issues raised as the metaverse matures in parallel with (or in advance of) policy guidance and regulation. Finally, we conclude with a research agenda that treats the metaverse as a serious topic of normative and empirical inquiry and argue for sustained engagement from diverse user communities to support its ethical design and development.
In today's digital era, secure and efficient management of health information is a critical challenge. Centralized health data systems often expose sensitive information to security risks, enabling unauthorized access, modifications, and data sharing without patients' consent. These challenges require a patient-centric, standardized approach to managing health data. This article presents a decentralized health information exchange framework that leverages blockchain technology to address these issues. The framework combines the Interplanetary File System for scalable data storage with Ethereum (ETH) smart contracts to enforce secure and transparent access control. By integrating these technologies, the proposed solution presented here enhances data security, transparency, and interoperability while reducing costs and reliance on intermediaries. Experiments conducted on the ETH blockchain demonstrate the framework's efficiency, with smart contracts evaluated for transaction costs and accuracy. In addition to examining scalability and security, the authors discuss the framework's limitations and its potential for broader application. To foster further research and collaboration, the source code for the smart contracts is openly available on GitHub.
As we head into 2026, artificial intelligence (AI), blockchain, and other emerging technologies are moving from experiments into core healthcare systems. That shift promises tangible benefits: fewer people left untreated, faster discovery of lifesaving treatments, and simpler, lower‑cost ways to move money and data across borders. It also brings real risks—speculative hype, erosion of institutional trust, and rushed rollouts that fail patients—so adoption must be disciplined and values-driven. This annual predictions article, informed by ConV2X Symposium speakers, highlights practical advances likely to matter at the bedside and beyond: programmable stablecoins that lower cross‑border payment friction; AI that surfaces pediatric risks earlier; verifiable digital credentials that ease clinician mobility; post‑quantum cryptography to safeguard sensitive records; domain‑specific AI designed for regulatory compliance; consumer apps that put usable health tools in people’s pockets; and the rise of Decentralized Science (DeSci) to restore transparency and funding momentum to stalled research. Realizing these possibilities will require deliberate choices, commitment, and coordinated stewardship across innovators, clinicians, and policymakers. With that effort, these tools can help build a more verifiable, equitable, and resilient global healthcare system—technology shaped to serve people, not the other way around; aspirations for healing, dignity, and universal well-being. While uncertainties persist, the path forward is clear: responsible innovation today will shape a healthier, more inclusive tomorrow.
